Mereo BioPharma Group plc (MPH.L) (LON:MPH) Stock Passes Below Fifty Day Moving Average of $26.50

Mereo BioPharma Group plc (MPH.L) (LON:MPHGet Rating) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 26.50 ($0.32) and traded as low as GBX 26 ($0.32). Mereo BioPharma Group plc (MPH.L) shares last traded at GBX 26.50 ($0.32), with a volume of 49,264 shares traded.

The company has a current ratio of 2.98, a quick ratio of 2.92 and a debt-to-equity ratio of 164.26. The firm has a market cap of £89.76 million and a price-to-earnings ratio of -0.21. The company’s 50-day moving average is GBX 26.50 and its 200-day moving average is GBX 26.50.

Mereo BioPharma Group plc (MPH.L) Company Profile (LON:MPH)

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.

Featured Stories

Want More Great Investing Ideas?

Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.